Influence of Induction Therapy Using Basiliximab With Delayed Tacrolimus Administration in Heart Transplant Recipients ― Comparison With Standard Tacrolimus-Based Triple Immunosuppression ―

Takuya Watanabe(Takeda (Japan)), Norihide Fukushima(National Cerebral and Cardiovascular Center), Yuki Kimura(Jichi Medical University), Kensuke Kuroda(National Cerebral and Cardiovascular Center), Yasumori Sujino(National Cerebral and Cardiovascular Center), Hiromi Takenaka(National Cerebral and Cardiovascular Center), Megumi Ikura(National Cerebral and Cardiovascular Center), Eiji Anegawa(National Cerebral and Cardiovascular Center), Osamu Seguchi(National Cerebral and Cardiovascular Center), Naoki Tadokoro(National Cerebral and Cardiovascular Center), Köichi Toda(The University of Osaka), Takashi Kakuta(National Cerebral and Cardiovascular Center), Shin Yajima(National Cerebral and Cardiovascular Center), Yorihiko Matsumoto(National Cerebral and Cardiovascular Center), Satsuki Fukushima(National Cerebral and Cardiovascular Center), Kazuki Nakagita(National Cerebral and Cardiovascular Center), Hatsue Ishibashi‐Ueda(United Cerebral Palsy), Tomoyuki Fujita(The University of Tokyo), Toshimitsu Hamasaki(National Cerebral and Cardiovascular Center), Keiichiro Iwasaki, Koichi Yoshitake(National Cerebral and Cardiovascular Center), Masanobu Yanase(National Cerebral and Cardiovascular Center), Hiroki Mochizuki(National Cerebral and Cardiovascular Center), Junjiro Kobayashi(National Cerebral and Cardiovascular Center), Kyoichi Wada(National Cerebral and Cardiovascular Center), Sachi Matsuda(National Cerebral and Cardiovascular Center), Yuto Kumai(National Cerebral and Cardiovascular Center), Seiko Nakajima(Tenri Hospital), Nobuichiro Yagi(National Cerebral and Cardiovascular Center)
Circulation Journal
November 2, 2020
Cited by 7


Related Papers